PCSA: Processa Pharmaceuticals, Inc. Stock

by  •  • Comments Off on PCSA: Processa Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.06
Enterprise Value ($M) -0.83
Book Value ($M) 3.72
Book Value / Share 1.14
Price / Book 0.55
NCAV ($M) 3.62
NCAV / Share 1.11
Price / NCAV 0.57

Profitability (mra)
Return on Invested Capital (ROIC) -3.02
Return on Assets (ROA) -1.99
Return on Equity (ROE) -2.31

Liquidity (mrq)
Quick Ratio 3.97
Current Ratio 3.97

Balance Sheet (mrq) ($M)
Current Assets 4.84
Assets 4.94
Liabilities 1.22
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Warrants n/a
Earnings Per Share Common Shares Issued And Outstanding Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Common Shares Issued And Outstanding Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-10-30 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-05 66,211 200,996 32.94
2025-02-04 38,972 176,285 22.11
2025-02-03 90,616 271,067 33.43
2025-01-31 155,648 534,773 29.11

(click for more detail)

Similar Companies
ORMP – Oramed Pharmaceuticals Inc. OTLK – Outlook Therapeutics, Inc.
PALI – Palisade Bio, Inc. PDSB – PDS Biotechnology Corporation
PHIO – Phio Pharmaceuticals Corp.


Financial data and stock pages provided by
Fintel.io